about
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacyBacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infectionThe era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy17β-estradiol ameliorates light-induced retinal damage in Sprague-Dawley rats by reducing oxidative stressNew Therapeutic Approaches in Diabetic Retinopathy.Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.Management of macular edema secondary to central retinal vein occlusion: an evidence-based.Deciphering combinations of PI3K/AKT/mTOR pathway drugs augmenting anti-angiogenic efficacy in vivo.The potential of nanomedicine therapies to treat neovascular disease in the retina.Use of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections.Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroidsInjectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo StudyOne-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection.Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.Preliminary study on electrophysiological changes after cellular autograft in age-related macular degenerationIncidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi ArabiaIntraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis.Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized studyInfluence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera.Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo.Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study.Antibacterial responses of retinal Müller glia: production of antimicrobial peptides, oxidative burst and phagocytosis.Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation.Adeno-associated virus (AAV) based gene therapy for eye diseases.Endophthalmitis following intravitreal injections.Drug delivery techniques for treating age-related macular degeneration.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Microrobots: a new era in ocular drug delivery.Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.Modeling intraocular bacterial infections.Novel pentablock copolymer-based nanoparticulate systems for sustained protein delivery.Novel thermosensitive pentablock copolymers for sustained delivery of proteins in the treatment of posterior segment diseases.
P2860
Q26849299-BDF4021E-34E2-4370-A88D-83F596CF7CC2Q26998053-2CFCA283-7C85-4C9C-A591-42D444AB6B3CQ28067341-1A9B02F6-78B0-4BCC-96CF-F16AE0730C52Q28573578-BCE759AE-FC6E-477D-BB4A-B73B590F086BQ33583037-092093B1-91C5-40C0-A165-81E2C30510F2Q33770558-386CCF86-6FD2-46C5-B034-845A012BE623Q33770564-6EF6C357-335C-4F66-9EDB-3E413831DD51Q34075366-DA211D16-D753-454F-B708-63FA30CE74C8Q34220590-13041555-8095-4492-8628-30FF020CAC69Q34357217-9268F727-557A-421E-9B49-E69D65BFB822Q34856993-6F105D8C-3E89-4D39-8EBE-BDCB8914B2C7Q35166714-ABB07198-3F13-4691-91CF-3872C369F051Q35167647-BE27FE85-DF00-4459-8D04-A51AF004876BQ35599811-24B3177F-DAF1-4E55-A0C0-31D9A91B1442Q35691908-15CA006C-3159-40AE-BDC5-58F785854E58Q35693314-70F59261-104E-469D-9A6A-224E84BE6D9CQ35774515-CD80EDD3-3A37-42D7-8193-70A560ACBDB6Q36151822-C47CE509-A6EB-42BD-8780-E62E919C835AQ36596476-8BB5F7E9-77FC-4E79-B3A8-29D9D03FD56AQ36622491-FC4CDED7-EB59-4781-B53B-4577F80CF91DQ36764415-143B33E6-2095-48A3-A441-170C8A2505B2Q36811157-660DC5EF-D1F0-4762-95F9-D2B6D2FE43A0Q36971794-E62D1EF1-234A-44E8-A13E-79B869DD574FQ37032753-C4E85AA3-1783-4D59-90D2-2A8B2E7CB364Q37274226-A413AF96-98F1-42F7-8F1C-F9DE22674C74Q37513330-6BF25ED4-0F84-43EB-8FB5-7E34345AC716Q37557535-3AA24858-B513-4D85-9D73-A86323F9BDD5Q37564990-CBB92C2A-2AD0-4634-BA96-3358D222C6C0Q37607511-08D91B36-DF2C-4F64-B110-766C0E343368Q37682513-90172581-AB68-4CCA-BAAF-3AD4428C6707Q37846117-16BC02AE-ED74-4EF6-917A-3C6274376BB4Q37952079-0BB9FF2E-DA4D-48EF-8F82-1CDCCF4CA5BEQ38161953-C165CB3D-D83F-4261-9465-CD6EC8245E07Q38168361-039EED41-AA37-4169-83D4-96F2480E2502Q38227020-208A53EE-F668-442F-98CE-C0034CE11D10Q38769853-32B7D5C1-B419-49B7-A4C5-C1F066C22319Q38811119-B4FC470A-F759-4AD5-A56C-1C3F444C89CBQ38827899-1A634A13-9901-45C9-8C0E-495C94620DD9Q38947571-C6BCED43-B109-47D4-AB04-D86B15B1E355Q38947876-0D925479-0E8C-4CFF-84A3-6E95112A0825
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complications of intravitreal injections.
@en
Complications of intravitreal injections.
@nl
type
label
Complications of intravitreal injections.
@en
Complications of intravitreal injections.
@nl
prefLabel
Complications of intravitreal injections.
@en
Complications of intravitreal injections.
@nl
P1476
Complications of intravitreal injections.
@en
P2093
Kapil M Sampat
Sunir J Garg
P304
P356
10.1097/ICU.0B013E328338679A
P577
2010-05-01T00:00:00Z